[go: up one dir, main page]

NO20061417L - Syreinneholdende oxaliplatinformuleringer - Google Patents

Syreinneholdende oxaliplatinformuleringer

Info

Publication number
NO20061417L
NO20061417L NO20061417A NO20061417A NO20061417L NO 20061417 L NO20061417 L NO 20061417L NO 20061417 A NO20061417 A NO 20061417A NO 20061417 A NO20061417 A NO 20061417A NO 20061417 L NO20061417 L NO 20061417L
Authority
NO
Norway
Prior art keywords
acid
formulation
containing oxaliplatin
oxaliplatin
oxaliplatin formulations
Prior art date
Application number
NO20061417A
Other languages
English (en)
Norwegian (no)
Inventor
Vanstone Darryl Whittaker
Julie Aikun Liu
Original Assignee
Mayne Pharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003904627A external-priority patent/AU2003904627A0/en
Application filed by Mayne Pharma Pty Ltd filed Critical Mayne Pharma Pty Ltd
Publication of NO20061417L publication Critical patent/NO20061417L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20061417A 2003-08-28 2006-03-28 Syreinneholdende oxaliplatinformuleringer NO20061417L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003904627A AU2003904627A0 (en) 2003-08-28 Pharmaceutical Formulation
PCT/AU2004/001168 WO2005020980A1 (fr) 2003-08-28 2004-08-27 Formulations d'oxaliplatine contenant de l'acide

Publications (1)

Publication Number Publication Date
NO20061417L true NO20061417L (no) 2006-03-28

Family

ID=34230045

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061417A NO20061417L (no) 2003-08-28 2006-03-28 Syreinneholdende oxaliplatinformuleringer

Country Status (10)

Country Link
US (5) US20050090544A1 (fr)
EP (2) EP1680103A4 (fr)
JP (4) JP2007504098A (fr)
CN (3) CN101022790A (fr)
CA (1) CA2537170A1 (fr)
DE (1) DE112004001563T5 (fr)
GB (1) GB2421911A (fr)
NO (1) NO20061417L (fr)
NZ (1) NZ545591A (fr)
WO (1) WO2005020980A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2388352A1 (fr) * 2002-05-31 2003-11-30 Voiceage Corporation Methode et dispositif pour l'amelioration selective en frequence de la hauteur de la parole synthetisee
NZ545591A (en) * 2003-08-28 2008-11-28 Mayne Pharma Ltd Acid containing oxaliplatin formulations
DE102004052877B4 (de) * 2004-11-02 2008-06-19 Ebewe Pharma Ges.M.B.H. Nfg.Kg Stabile wässrige Formulierungen eines Platin-Derivats
DE102005038347A1 (de) * 2005-08-11 2007-02-15 Hexal Ag Herstellung einer Oxaliplatin-Lösung und Behälter sowie Behälter-Set mit der Lösung
WO2007029268A2 (fr) * 2005-09-05 2007-03-15 Dabur Pharma Limited Formulation stable d'oxaliplatine
KR100913063B1 (ko) 2006-09-13 2009-08-21 주식회사유한양행 옥살리플라틴-함유 주사용 용액
US20100267824A1 (en) * 2007-11-12 2010-10-21 Intas Pharmaceuticals Limited Stable oxaliplatin composition for parenteral administration
CN101461801B (zh) * 2008-12-26 2013-05-15 辰欣药业股份有限公司 一种奥沙利铂药物组合物及其制备方法
MX348668B (es) 2009-09-21 2017-06-23 J W Pharmaceutical Corp * Nanopartículas de oxaliplatin y método para prepararlas.
JP5929607B2 (ja) * 2012-08-06 2016-06-08 ニプロ株式会社 オキサリプラチン製剤
HRP20190245T1 (hr) * 2013-04-26 2019-04-05 Sanofi Tartratna sol [(s)-2-[metil-3-(2-okso-pirolidin-1-il)-benzensulfonilamino]-3-(4-metil piperazin-1 -il)-3-okso-propril]amida 5-kloro-tiofen-2-karboksilne kiseline

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US19514A (en) * 1858-03-02 Improvement in seeding-machines
IL114852A (en) * 1994-08-08 2000-02-29 Debiopharm Sa Pharmaceutically stable preparation of oxaliplatinum
WO1997033894A1 (fr) * 1996-03-11 1997-09-18 Debiopharm Sa Complexes de platine dinucleaires, procede pour leur preparation et compositions pharmaceutiques en contenant
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations
PT1207875E (pt) * 1999-08-30 2004-02-27 Debiopharm Sa Preparacao farmaceutica estavel de oxaliplatina para administracao via parenteral
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
DE10314377A1 (de) * 2003-03-28 2004-10-07 Stada Arzneimittel Ag Gebrauchsfertige Oxaliplatin-Lösungen
NZ545591A (en) * 2003-08-28 2008-11-28 Mayne Pharma Ltd Acid containing oxaliplatin formulations
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions

Also Published As

Publication number Publication date
DE112004001563T5 (de) 2006-07-27
WO2005020980A1 (fr) 2005-03-10
CN101703467A (zh) 2010-05-12
GB0606187D0 (en) 2006-05-10
US20060264501A1 (en) 2006-11-23
JP2014080426A (ja) 2014-05-08
JP6078593B2 (ja) 2017-02-08
US20050090544A1 (en) 2005-04-28
CN101022790A (zh) 2007-08-22
CN102048723A (zh) 2011-05-11
US20070155833A1 (en) 2007-07-05
NZ545591A (en) 2008-11-28
EP2243480A1 (fr) 2010-10-27
JP2015180699A (ja) 2015-10-15
GB2421911A (en) 2006-07-12
EP1680103A4 (fr) 2009-03-25
JP2008201804A (ja) 2008-09-04
HK1111894A1 (zh) 2008-08-22
US20100035982A1 (en) 2010-02-11
US20100063145A1 (en) 2010-03-11
EP1680103A1 (fr) 2006-07-19
JP2007504098A (ja) 2007-03-01
JP2012072191A (ja) 2012-04-12
CA2537170A1 (fr) 2005-03-10

Similar Documents

Publication Publication Date Title
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
WO2003079979A3 (fr) Procede de traitement d'insuffisance cardiaque globale
GEP20063895B (en) Platinum derivative pharmaceutical formulations
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
NO20050204L (no) Kombinasjoner av legemidler for behandling av neoplasmer
MXPA05008617A (es) Usos de anticuerpos anti-receptor del factor de crecimiento semejante a la insulina i.
RU2007132181A (ru) ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ
NO20071426L (no) Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib
CY1108217T1 (el) Μεθοδος χορηγησης βουπρενορφινης για τη θεραπεια της καταθλιψης
UA86977C2 (ru) Производные гидантоина для лечения обструктивных болезней дыхательных путей
NO20061417L (no) Syreinneholdende oxaliplatinformuleringer
BRPI0415953A (pt) formulação de dosagem de liberação controlada oral, método de tratamento de um distúrbio, conjunto de formas de dosagem de liberação controlada e método para administração da formulação
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
MX2009003532A (es) Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina.
NO20101070L (no) Fremgangsmate til dosering av et medikament, samt doseringsform
IS8187A (is) Meðferð á fráhvarfseinkennum
WO2004006849A3 (fr) Combinaisons de medicaments pour le traitement de neoplasmes
WO2004071397A3 (fr) Polytherapie
WO2004007676A3 (fr) Therapie combinee servant a traiter des tumeurs
JP2003528919A5 (fr)
NO20063277L (no) Farmasoytisk sammensetning av vinflunin som er ment for parenteral administrering, fremstillingsmate og anvendelse derav
IS8186A (is) Meðferð fyrir uppskurð á verkjum eftir uppskurð
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE421882T1 (de) Schnellösliches azithromycin in einzeldosisform
TW418100B (en) Device for transdermal and phonophoretic combination treatment and its therapeutic uses

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application